clinical trial · NCT04569227
Prevention of COVID-19 Infection to Severe Pneumonia or ARDS
Covid19 PneumoniaEC-18Placebo
brief summary
A trial of EC-18 in patients with mild/moderate pneumonia due to COVID-19
started
Apr 30, 2021
primary completion
Sep 1, 2021
completion
Nov 1, 2021
last updated
Aug 20, 2026
official title
Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of EC-18 in Preventing the Progression of COVID-19 Infection to Severe Pneumonia or ARDS
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol